The in-vitro activity of roxithromycin against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum, Treponema pallidum, Gardnerella vaginalis and Haemophilus ducreyi is reviewed. Roxithromycin demonstrated equivalent activity to erythromycin against N. gonorrhoeae, C. trachomatis, M. hominis, U. urealyticum, G. vaginalis and H. ducreyi. In a rabbit model for syphilis, potentially useful activity against T. pallidum has been demonstrated. © 1987 The British Society for Antimicrobial Chemotherapy.
CITATION STYLE
Ridgway, G. L. (1987). A Review of the In-Vitro Activity of Roxithromycin Against Genital Pathogens. Journal of Antimicrobial Chemotherapy, 20, 7–11. https://doi.org/10.1093/jac/20.suppl_B.7
Mendeley helps you to discover research relevant for your work.